Urinary Incontinence in US Adults with Diabetes Recommended for SGLT2 Inhibitors
Author Information
Author(s): Lee Alexandra, Lee Sei
Primary Institution: University of California San Francisco
Hypothesis
What is the prevalence of urinary incontinence among adults with diabetes who are recommended to receive SGLT2 inhibitors?
Conclusion
Among adults with diabetes, a significant percentage of those recommended for SGLT2 inhibitors also experience frequent urinary incontinence.
Supporting Evidence
- 14.9% of adults aged 55-59 recommended for SGLT2 inhibitors had frequent incontinence.
- 22.7% of those recommended for SGLT2 inhibitors aged 55-59 experienced frequent incontinence.
- 27.0% of adults aged 70+ were recommended for SGLT2 inhibitors, with 41.0% having frequent incontinence.
- 54.6% of adults aged 55-59 were recommended for either SGLT2 inhibitors or GLP-1RAs, with 20.6% having frequent incontinence.
- 45.1% of adults aged 70+ were recommended for either SGLT2 inhibitors or GLP-1RAs, with 34.9% having frequent incontinence.
Takeaway
Many older adults with diabetes who are supposed to take a certain medication also have a problem with leaking urine, which can be a concern for their health.
Methodology
Participants with diabetes from NHANES 2013-2020 were analyzed for guideline recommendations for SGLT2 inhibitors and reported urinary incontinence.
Potential Biases
Potential bias in self-reporting of urinary incontinence.
Limitations
The study is limited to self-reported data on urinary incontinence and may not capture all cases.
Participant Demographics
Adults aged 55-59 and 70+ with type 2 diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website